rs3813774
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_032447.5(FBN3):c.1929C>T(p.Cys643=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0715 in 1,614,004 control chromosomes in the GnomAD database, including 5,623 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 1087 hom., cov: 33)
Exomes 𝑓: 0.068 ( 4536 hom. )
Consequence
FBN3
NM_032447.5 synonymous
NM_032447.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.19
Genes affected
FBN3 (HGNC:18794): (fibrillin 3) This gene encodes a memebr of the fibrillin protein family. Fibrillins are extracellular matrix molecules that assemble into microfibrils in many connective tissues. This gene is most highly expressed in fetal tissues and its protein product is localized to extracellular microfibrils of developing skeletal elements, skin, lung, kidney, and skeletal muscle. This gene is potentially involved in Weill-Marchesani syndrome. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 19-8131615-G-A is Benign according to our data. Variant chr19-8131615-G-A is described in ClinVar as [Benign]. Clinvar id is 1288401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.205 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN3 | NM_032447.5 | c.1929C>T | p.Cys643= | synonymous_variant | 15/64 | ENST00000600128.6 | NP_115823.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN3 | ENST00000600128.6 | c.1929C>T | p.Cys643= | synonymous_variant | 15/64 | 1 | NM_032447.5 | ENSP00000470498 | ||
FBN3 | ENST00000270509.6 | c.1929C>T | p.Cys643= | synonymous_variant | 14/63 | 1 | ENSP00000270509 | |||
FBN3 | ENST00000601739.5 | c.1929C>T | p.Cys643= | synonymous_variant | 15/64 | 1 | ENSP00000472324 | |||
FBN3 | ENST00000651877.1 | c.2055C>T | p.Cys685= | synonymous_variant | 15/64 | ENSP00000498507 | P1 |
Frequencies
GnomAD3 genomes AF: 0.101 AC: 15311AN: 152158Hom.: 1087 Cov.: 33
GnomAD3 genomes
AF:
AC:
15311
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0765 AC: 19208AN: 251008Hom.: 1168 AF XY: 0.0734 AC XY: 9960AN XY: 135680
GnomAD3 exomes
AF:
AC:
19208
AN:
251008
Hom.:
AF XY:
AC XY:
9960
AN XY:
135680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0685 AC: 100073AN: 1461728Hom.: 4536 Cov.: 65 AF XY: 0.0678 AC XY: 49301AN XY: 727144
GnomAD4 exome
AF:
AC:
100073
AN:
1461728
Hom.:
Cov.:
65
AF XY:
AC XY:
49301
AN XY:
727144
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.101 AC: 15330AN: 152276Hom.: 1087 Cov.: 33 AF XY: 0.0987 AC XY: 7349AN XY: 74468
GnomAD4 genome
AF:
AC:
15330
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
7349
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
368
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 14, 2020 | - - |
FBN3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 22, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at